Company Overview of Ganderland & Associates, Inc.
Ganderland & Associates, Inc., an actualization company, brings concepts, inventions, and products to the market from various points in their realization. Its products include new medications, new medical instruments, new treatment modalities, etc. The company is working on patenting and preparing a new medication for people living with multiple Sclerosis. Ganderland & Associates, Inc. was incorporated in 2015 and is based in New York, New York.
200 Park Avenue
New York, NY 10168
Founded in 2015
Key Executives for Ganderland & Associates, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ganderland & Associates, Inc., please visit www.ganderlandinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.